Ureteropelvic junction obstruction overview

Revision as of 12:53, 28 September 2012 by Prashanthsaddala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Ureteropelvic junction obstruction Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ureteropelvic junction obstruction from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ureteropelvic junction obstruction overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ureteropelvic junction obstruction overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ureteropelvic junction obstruction overview

CDC on Ureteropelvic junction obstruction overview

Ureteropelvic junction obstruction overview in the news

Blogs on Ureteropelvic junction obstruction overview

Directions to Hospitals Treating Ureteropelvic junction obstruction

Risk calculators and risk factors for Ureteropelvic junction obstruction overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ureteropelvic junction (UPJ) obstruction is a blockage in the area that connects the renal pelvis (part of the kidney) to one of the tubes (ureters) that move urine to the bladder.

Ureteropelvic junction obstruction (UPJO) is defined as functional or anatomic obstruction to urine flow from the renal pelvis into the ureter at their anatomic junction. [1]

If left untreated, results in symptoms, renal damage, or both.

UPJO generally implies a congenital partial proximal ureteric obstruction detected in utero or in later life.

Salient Features

  • The ureterovascular tangle is a term that embraces the renal pelvis, ureter, and adjacent vessels (both arterial and venous), all of which alone or in combination have been implicated as potential causes of UPJO.
    • The Vasculature: In the context of UPJO, "crossing vessels" are those renal arteries or veins found in the region of the ureteric transition point.
    • The Ureter: The normal ureter inserts at the inferior aspect of the renal pelvis at an oblique angle and with gradual taper. It has been noted that in the setting of UPJO, the ureter tends to have a more cephalad or acute insertion.
  • Therapy: Characteristic symptoms with morphologic evidence of UPJO may indicate a need for therapy.
  • Such symptoms include intermittent pain after drinking large volumes of fluid or fluids with a diuretic effect.
  • Asymptomatic UPJO may be treated if there is evidence of asymmetric function or deterioration in renal function or hydronephrosis.

References

  1. Leo P. Lawler, Thomas W. Jarret, Frank M. Corl, and Elliot K. Fishman. Adult Ureteropelvic Junction Obstruction: Insights with Three-dimensional Multi–Detector Row CT. RadioGraphics 2005 25: 121-134.


Template:WikiDoc Sources